Palisade Bio (PALI) Free Cash Flow (2010 - 2026)
Palisade Bio's (PALI) quarterly Free Cash Flow came in at -$3.9 million in Q1 2026, down 66.74% year-on-year from -$11.7 million in Q1 2025, and down 23.73% on a QoQ basis from -$3.1 million in Q4 2025.
Palisade Bio (PALI) Free Cash Flow (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Free Cash Flow data on file, last reported at -$3.9 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 66.74% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was -$12.4 million, a 9.32% decrease from a year earlier, with the FY2025 full-year figure at -$10.8 million, up 11.04% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$3.9 million, down from -$3.1 million in the prior quarter.
- Over the last five years, Free Cash Flow for PALI reached as high as -$1.8 million in Q2 2025 and fell as low as -$3.9 million in Q1 2026.
- Historically, Free Cash Flow has averaged -$3.0 million across 5 years, with a median of -$3.1 million in 2025.
- On a YoY basis, Free Cash Flow climbed as much as 57.91% in 2022 and fell as far as 201.12% in 2022.
- Year by year, Free Cash Flow stood at -$3.3 million in 2022, then climbed by 17.19% to -$2.7 million in 2023, then gained by 13.29% to -$2.4 million in 2024, then tumbled by 32.05% to -$3.1 million in 2025, then fell by 23.73% to -$3.9 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$3.9 million in Q1 2026, -$3.1 million in Q4 2025, and -$3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Dec 31, 2023 | -2.75 Mn |